With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Studies estimate that it now costs up to $2bn to bring a new drug to market 4 and according to one study the average length of time from the start of clinical testing to approval is 7.1 years. 5 ...

That clinical trial didn’t just give me time — it gave me back my life. My story brings hope, but it also highlights a difficult truth: Too few patients participate in clinical trials.

Melinda Bachini, a 15-year cholangiocarcinoma survivor, highlights the life-saving potential of clinical trials and advocates for increased access and participation. In April 2012, I walked into the ...

In a recent Regeneron survey, conducted by The Harris Poll in July and August 2024 among 100 U.S. adults 18+ who participated in a clinical trial in the past five years, nearly half (48%) reported ...

As clinical trials continue to grow in complexity, the adoption of these advanced data visualization tools will be crucial for driving innovation and achieving better patient outcomes.